← FDA DRUG APPROVALS

FDA ANDA · ANDA077280

GLIMEPIRIDE

Sponsor: WATSON LABS

APPLICATION
ANDA077280
TYPE
ANDA
ORIGINAL APPROVAL
2006-02-03
LATEST ACTION
2010-01-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GLIMEPIRIDEDiscontinued
GLIMEPIRIDE 4MG · TABLET · ORAL
GLIMEPIRIDEDiscontinued
GLIMEPIRIDE 1MG · TABLET · ORAL
GLIMEPIRIDEDiscontinued
GLIMEPIRIDE 2MG · TABLET · ORAL

Approval history

2010-01-19Labeling · Supplement 4AP
2008-06-29Labeling · Supplement 2AP
2006-02-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →